Approaching clinical proteomics: current state and future fields of application in fluid proteomics. - sprookjes - yvandenbroek - TriplyDB

Approaching clinical proteomics: current state and future fields of application in fluid proteomics.

Approaching clinical proteomics: current state and future fields of application in fluid proteomics.

http://www.wikidata.org/entity/Q33467523

about

Lost in Translation (LiT): IUPHAR Review 6 Biomarkers in Alzheimer's disease analysis by mass spectrometry-based proteomics Evaluation of optical detection platforms for multiplexed detection of proteins and the need for point-of-care biosensors for clinical use Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.Comparison of different depletion strategies for improving resolution of the human urine proteome.The Use of Proteomics in Assisted Reproduction.The role of proteomics in the diagnosis of chorioamnionitis and early-onset neonatal sepsis.Biomarkers for Early Cancer Detection - Methodological Aspects.Ovine serum biomarkers of early and late phase scrapie.Novel effects of hormonal contraceptive use on the plasma proteome.Potential role of proteomics in the diagnosis of lymphoma: a meta-analysis.Analytical challenges translating mass spectrometry-based phosphoproteomics from discovery to clinical applications.Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration.Progress in mining the human proteome for disease applications Application of Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Imaging Mass Spectrometry (MALDI-TOF IMS) for Premalignant Gastrointestinal Lesions.Biospecimen Reporting for Improved Study Quality.Biospecimen reporting for improved study quality (BRISQ)Mass spectrometry-based proteomics: qualitative identification to activity-based protein profiling.Integrating the multiple dimensions of genomic and epigenomic landscapes of cancer.Clinical proteomics Searching for the noninvasive biomarker holy grail: are urine proteomics the answer?Quality assessment for clinical proteomics.Performance evaluation of a multiplex assay for future use in biomarker discovery efforts to predict body composition Esterase D and gamma 1 actin level might predict results of induction therapy in patients with acute myeloid leukemia without and with maturation.Comparative and Quantitative Global Proteomics Approaches: An Overview.Proteomic methodologies and their application in colorectal cancer research.Tissue and serum proteomic profiling for diagnostic and prognostic bladder cancer biomarkers.Biomarkers for the prediction of type 2 diabetes and cardiovascular disease.Biomarkers in Sporadic and Familial Alzheimer's Disease.Direct Assessment of Plasma/Serum Sample Quality for Proteomics Biomarker Investigation.Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast.Update on current applications of proteomic in the study of inflammatory bowel disease.Comparative proteomics in acute myeloid leukemia.Improved protocols for vibrational spectroscopic analysis of body fluids.ExSTA: External Standard Addition Method for Accurate High-Throughput Quantitation in Targeted Proteomics Experiments.Ratiometric Fluorescence Detection of Phosphorylated Amino Acids Through Excited-State Proton Transfer by Using Molecularly Imprinted Polymer (MIP) Recognition Nanolayers.Evolving Relevance of Neuroproteomics in Alzheimer's Disease.Female urinary proteomics: New insight into exogenous and physiological hormone-dependent changes.Mining proteomic data for biomedical research Biospecimen reporting for improved study quality (BRISQ)

P2860

Q24289150-321A222C-1A0E-416F-A08C-6C541A2E878E Q27024518-DD7C1C90-B450-41C2-9AAD-79F55C1EE366 Q28652076-3276F80F-2C43-4094-94A0-DE42A05FAE76 Q33520447-A0D2AD2F-D3C1-47A8-B24E-37A88BDA5AEF Q33530681-C07E6103-5CC8-4A45-ACFE-1082C645DA81 Q33770728-277A6946-F556-4D38-95F4-8446859FAACC Q33940421-0456D9C2-3199-479B-9D22-CBB9550039ED Q34095989-FF7B7CA4-9940-47E8-90D8-CB3B6E932EEC Q34332056-C100C9AC-4BB3-495E-B990-0DC7F524251F Q34416417-FD1F93C9-3A66-4B0C-9773-C436688EDDD8 Q34502670-841C8760-C79D-4E9F-81F4-6E2C5791E6EA Q34604043-6424F7A6-58AF-47C4-A123-FE256DFC2A2F Q35042433-DF7001FB-703B-411E-88A2-82F1287CFDE1 Q35056154-76DDE2D8-5438-43EC-889E-09A7C53B892E Q35068096-29A20941-DFB4-4F68-83D2-2A6E61917682 Q35125775-B7EDE604-39C6-4786-8A2B-97487F928509 Q35203154-22223CAB-C4BD-4847-9666-44A5C58E475B Q35782819-16B5CB7F-F336-4252-8E21-5094A668CDE5 Q36152246-9C7C765D-09A6-42F1-A6A3-462339C77C58 Q36184748-10D23DB1-9A33-4900-BDCB-6DAD5549FAE7 Q36601626-0C546DDF-A3B5-4A45-89FE-DCA10D0B27BC Q36698467-5F7EAFE2-5F1E-4227-BC24-29EDF78BF490 Q37109805-D689D949-CB12-4E64-8D8C-AC42D6FB2364 Q37342223-35368105-E865-4B11-B8C1-E4C62328E4EE Q37636378-A5B2F650-4D0A-4823-9AE1-F1E3F10E4F1C Q37643738-38D69857-3600-4E26-B00F-91DD1F7D8056 Q37818317-FC44AA4B-0D26-4017-97A6-EE89B7527A57 Q37886659-7289B27F-132A-47B8-87A5-931506FC05A8 Q38592041-7915D205-0301-4ED1-B2E9-1B0B6AFBBF3F Q39413046-5C9EC7A4-1303-40B5-973F-5C461A9E66C1 Q41130687-09EA404A-57E8-428D-A8D6-C3EF584FFD44 Q42406649-049B8DB0-B654-442D-9046-77F986293A1B Q43121205-9CBFD9DB-1119-44B1-98E1-F7F669A097C3 Q45979897-8CDBEB38-CFA2-48D1-ABB8-B0E876642C4A Q47818859-B79797CA-CF89-4BB1-B28D-0B4ABD1BD946 Q48133159-1FABFD4A-83BA-4BDA-914A-A8C0C163B1BE Q50999408-BF34E959-45E0-498E-AFB7-2E524481572B Q51462040-C1EDBE5E-2E93-4C8E-982E-B19D365E73F4 Q56881273-01E39C20-EF2D-471F-9645-C5CE79DE9132 Q57419587-BAA0D684-FF95-4D97-B2F1-659A04FDF076

P2860

Approaching clinical proteomics: current state and future fields of application in fluid proteomics.

http://www.wikidata.org/entity/Q33467523

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Approaching clinical proteomic ...... plication in fluid proteomics.

@ast

Approaching clinical proteomic ...... plication in fluid proteomics.

@en

type

label

Approaching clinical proteomic ...... plication in fluid proteomics.

@ast

Approaching clinical proteomic ...... plication in fluid proteomics.

@en

prefLabel

Approaching clinical proteomic ...... plication in fluid proteomics.

@ast

Approaching clinical proteomic ...... plication in fluid proteomics.

@en

P1433

Q33467523-0792E573-A1FD-4625-9707-887A9AA2DBEC

P1476

Q33467523-2C8F0914-9361-45AD-8668-60ABFA6A1576

P2093

Q33467523-0106F282-73CF-4492-8923-32215FD35F24

Q33467523-11EB5336-5BB6-4A1D-9CE9-785554CA3167

Q33467523-1AF0802D-D307-4F53-8B8E-7265AA11706C

Q33467523-1D386596-8596-42CE-B35F-E16AD7A6505D

Q33467523-2A930480-CA5F-4326-8848-5CB925DBFCD3

Q33467523-361838CE-96A6-4E11-AB7D-4400875331D2

Q33467523-3B7AEA45-92B0-4A9F-89ED-AA3936191D1D

Q33467523-412AD088-02E4-41DA-BE3C-E34F38DCEAFD

Q33467523-5B9BFCB3-5615-4F84-9826-8788B339CAC2

Q33467523-61732BE1-2791-4199-AF6D-4B0529A6CB87

P2860

Q33467523-0102A0EF-32E1-4100-AEE2-B864AC2375A5

Q33467523-02F9BD6A-33E5-44C7-9333-1147E007C61C

Q33467523-04317023-DB52-42C0-9BA3-244062C88557

Q33467523-05384D2B-89E1-4EFE-A914-42407C2F9817

Q33467523-0C0CB362-9DE1-474A-A5F6-A7CCB3EF1C16

Q33467523-0E2FA921-A480-480D-A9A7-9A298D17C912

Q33467523-0F2747E5-3518-444F-9EC6-EC932197EB67

Q33467523-10046786-BA49-4C8F-BC05-3F4BFD3FF249

Q33467523-16522D85-B4D5-43D6-9DE0-B7F0BD9E153D

Q33467523-1811CC6E-2ED8-4A7D-BF90-211E0F1E8CB0

P304

Q33467523-E93BCC7C-C041-4223-870E-93A292BB5ACC

P31

Q33467523-54CAD499-B2C7-4432-9B26-C0DDE953ABA0

P356

Q33467523-BC567AF4-BC3E-46ED-AE08-E7670DC17CD1

P433

Q33467523-64078730-9024-47E7-BC02-23063915B0F9

P478

Q33467523-AF621620-B8BD-4029-AF3D-FA6912A4E8E6

P50

Q33467523-0DDACDA4-CB19-4654-88FA-AB0598801091

Q33467523-1A2F341B-EC5D-4834-BBE8-A95507B143A1

Q33467523-3261C117-204C-472C-9295-27E1CEC2F71A

Q33467523-6ACB3FE1-160E-4731-83B8-07A23B316106

Q33467523-94C82BAE-664B-4622-81E1-D34BAF3B7DEE

Q33467523-99453B6C-E884-4C39-B48D-78A4CE6B50D7

Q33467523-9A2E5E3C-A2E8-4259-88B8-922569AEB7F5

Q33467523-DA170A4D-6860-4AEA-B636-B7383910DC06

P577

Q33467523-334D94CF-BB07-41D7-8BD2-8B8F28DB3610

P698

Q33467523-ACC3B912-0B90-4932-905C-EA1C4C7ABDA3

P356

P1433

Clinical Chemistry and Laboratory Medicine

P1476

Approaching clinical proteomic ...... plication in fluid proteomics.

@en

P2093

Andreas Radbruch

http://www.w3.org/2001/XMLSchema#string

Andreas Thiel

http://www.w3.org/2001/XMLSchema#string

Attila Tarnok

http://www.w3.org/2001/XMLSchema#string

Charalampos Aslanidis

http://www.w3.org/2001/XMLSchema#string

Christoph Wagener

http://www.w3.org/2001/XMLSchema#string

Dennis Hochstrasser

http://www.w3.org/2001/XMLSchema#string

Edmund Maser

http://www.w3.org/2001/XMLSchema#string

Friedrich Lottspeich

http://www.w3.org/2001/XMLSchema#string

Gregor Rothe

http://www.w3.org/2001/XMLSchema#string

Günther Valet

http://www.w3.org/2001/XMLSchema#string

P2860

Probability-based protein identification by searching sequence databases using mass spectrometry data

Large-scale analysis of the yeast proteome by multidimensional protein identification technology

OLAV: towards high-throughput tandem mass spectrometry data identification

Structure and biology of complement protein C3, a connecting link between innate and acquired immunity

Clinical proteomics: written in blood

The human plasma proteome: history, character, and diagnostic prospects

Difference gel electrophoresis: a single gel method for detecting changes in protein extracts

Influence of the needle bore size on platelet count and routine coagulation testing

Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices

Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons

P304

724-744

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1515/CCLM.2009.167

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P50

Hans-Werner Mewes

Hannes Stockinger

Fredrik Pontén

Andreas Gerstner

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19527139

http://www.w3.org/2001/XMLSchema#string